[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340613-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340613-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-potential-of-oncolytic-virotherapy-in-the-treatment-of-head-and-neck-cancer-a-comprehensive-review","The Potential of Oncolytic Virotherapy in the Treatment of Head and Neck Cancer: A Comprehensive Review","","Head and neck cancer presents high morbidity and mortality, and even with improved standard modalities such as surgery, chemotherapy, and radiation, outcomes for advanced disease remain limited. Oncolytic virotherapy has emerged as a promising strategy, and this review consolidates current knowledge on oncolytic viruses in HNC. It details mechanisms of action, highlights preclinical and clinical evidence, and analyzes key challenges. Future directions emphasize better delivery, tumor targeting, and immune activation through nanoparticle carriers, genetic engineering, and combinations with immunotherapies such as checkpoint inhibitors, supported by personalized care and rigorous trials.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-potential-of-oncolytic-virotherapy-in-the-treatment-of-head-and-neck-cancer-a-comprehensive-review/340613/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-potential-of-oncolytic-virotherapy-in-the-treatment-of-head-and-neck-cancer-a-comprehensive-review/340613.png","ImageObject",300,407,{"name":42,"@type":43},"Genevieve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the review focus on regarding head and neck cancer treatment?","Question",{"text":63,"@type":64},"It reviews the role of oncolytic virotherapy in treating head and neck cancer, covering mechanisms, evidence from preclinical and clinical studies, challenges, and future directions.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do standard therapies for head and neck cancer compare with oncolytic virotherapy?",{"text":68,"@type":64},"Standard treatments include surgery, chemotherapy, and radiation, but outcomes for advanced cases are still suboptimal. The review positions oncolytic virotherapy as an emerging therapeutic approach aimed at improving results.",{"name":70,"@type":61,"acceptedAnswer":71},"What future strategies does the review emphasize for oncolytic virotherapy?",{"text":72,"@type":64},"It emphasizes improving delivery and specificity using nanoparticle carriers and genetic modifications to enhance tumor targeting and immune response, including combination approaches with immunotherapies such as checkpoint inhibitors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340613,1790192676,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review  \nThe Potential of Oncolytic Virotherapy in the Treatment of Head and Neck Cancer: A Comprehensive Review  \nFrancesca Spirito 1, *, Riccardo Nocini 2, Giorgio Mori 1, Massimo Albanese 2, Eleni A. Georgakopoulou 3, Gowri Sivaramakrishnan 4, Basel Khalil 5, Bruno Špiljak 6, Varun Surya 7, Deepika Mishra 7 and Akhilanand Chaurasia 8  \nCitation: Spirito, F.; Nocini, R.; Mori, G.; Albanese, M.; Georgakopoulou, E.A.; Sivaramakrishnan, G.; Khalil, B.;Špiljak, B.; Surya, V.; Mishra, D.; et al. The Potential of Oncolytic Virotherapy in the Treatment of Head and Neck Cancer: A Comprehensive Review. Int. J. Mol. Sci. 2024, 25, 12990 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms252312990  \nAcademic Editor: Erik A.C. Wiemer  \nReceived: 16 October 2024  \nRevised: 21 November 2024  \nAccepted: 28 November 2024  \nPublished: 3 December 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy; [giorgio.mori@unifg.it](giorgio.mori@unifg.it)  \n2 Department of Surgical Sciences, Dentistry, Gynaecology and Paediatrics, University of Verona,  \n37134 Verona, Italy; [riccardo.nocini@gmail.com](riccardo.nocini@gmail.com) (R.N.); [massimo.albanese@univr.it](massimo.albanese@univr.it) (M.A.)  \n3 Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece; [eageorgakopoulou@gmail.com](eageorgakopoulou@gmail.com)  \n4 Bahrain Defence Force Royal Medical Services, Riffa 28743, Bahrain; [gowri.sivaramakrishnan@gmail.com](gowri.sivaramakrishnan@gmail.com)  \n5 Department of Basic Sciences, Faculty of Dentistry, University of Damascus, Damascus 30621, Syria  \n6 Department of Oral Medicine, School of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia; [bspiljak@sfzg.unizg.hr](bspiljak@sfzg.unizg.hr)  \n7 Department of Oral Pathology and Microbiology, Centre for Dental Educationand Research, All India Institute of Medical Sciences, New Delhi 110029, India; [drvarunsuryamds@gmail.com](drvarunsuryamds@gmail.com) (V.S.); [deepika1904@gmail.com](deepika1904@gmail.com) (D.M.)  \n8 Department of Oral Medicine and Radiology, King George’s Medical University, Lucknow 226003, India; [chaurasiaakhilanand49@gmail.com](chaurasiaakhilanand49@gmail.com)  \n* Correspondence: francesca.spirito@unifg.it  \nAbstract: Head and neck cancer (HNC) represents a challenging oncological entity with significant morbidity and mortality rates. Despite advances in conventional therapies, including surgery, chemotherapy, and radiation therapy, the overall survival rates for advanced HNC remain suboptimal. In recent years, the emerging field of oncolytic virotherapy has gained attention as a promising therapeutic approach for various malignancies, including HNC. This review provides a comprehensive overview of the current understanding of oncolytic viruses (Ovs) in the context of HNC treatment, including their mechanisms of action, preclinical and clinical studies, challenges, and future directions. Future oncolytic virotherapy focuses on improving delivery and specificity through nanoparticle carriers and genetic modifications to enhance tumor targeting and immune response. Combining different OVs and integrating them with immunotherapies, such as checkpoint inhibitors, could overcome tumor resistance and improve outcomes. Personalized approaches and rigorous clinical trials are key to ensuring the safety and effectiveness of virotherapy in treating HNC.  \nKeywords: head and neck cancer; squamous cell carcinoma; oncolytic virus; therapy  \n1. Introduction  \n1.1. Head and Neck Squam","cbCaii1zqn2B79FI","https://ap.wps.com/l/cbCaii1zqn2B79FI","pdf",450430,34,"English","# Abstract\n# Keywords\n# 1. Introduction\n## 1.1. Head and Neck Squamous Cell Carcinoma: Epidemiology, Diagnosis, and Treatment Options\n## 1.2. Oncolytic Virotherapy: A Resurgent Strategy in Cancer Treatment","[{\"question\":\"What does the review focus on regarding head and neck cancer treatment?\",\"answer\":\"It reviews the role of oncolytic virotherapy in treating head and neck cancer, covering mechanisms, evidence from preclinical and clinical studies, challenges, and future directions.\"},{\"question\":\"How do standard therapies for head and neck cancer compare with oncolytic virotherapy?\",\"answer\":\"Standard treatments include surgery, chemotherapy, and radiation, but outcomes for advanced cases are still suboptimal. The review positions oncolytic virotherapy as an emerging therapeutic approach aimed at improving results.\"},{\"question\":\"What future strategies does the review emphasize for oncolytic virotherapy?\",\"answer\":\"It emphasizes improving delivery and specificity using nanoparticle carriers and genetic modifications to enhance tumor targeting and immune response, including combination approaches with immunotherapies such as checkpoint inhibitors.\"}]","The Potential of Oncolytic Virotherapy in the Treatment of Head and Neck Cancer: A Comprehensive Review | PDF",1790037697,86,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7037a43972ecffedfb34a89b14c7bba8.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c400181c7cec7b0b226be7e5e5884f0.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c94d4633761548a998ce6bf048c8bbb.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9b8c5062205b3521fbc36ad1e3b1aa2.webp",980,1385]